Statens Serum Institut (SSI) consists of a management board, three health priority areas and staff units – all with their own departments.

SSI - Organisation chart

See the organisation chart as a pdf.

Management board

Mads Melbye (President & CEO)
Ole Jensen (Executive Vice President)
Helle Birk Krogsgaard (Chief Financial Officer)

Supported by Executive Vice Presidents for:


Corporate Affairs
Center for Biosecurity & Biopreparedness 

Business Support & Campus (Helle Birk Krogsgaard, Chief Financial Officer)

Business Development

Infectious Disease Preparedness (Kåre Mølbak, Executive Vice President)

Infectious Disease Preparedness
Infectious Disease Epidemiology & Prevention
Bacteria, Parasites & Fungi
Virus & Microbiological Special Diagnostics
International Reference Laboratory of Mycobacteriology

Danish National Biobank & Biomarkers (Helle B. Konradsen, Executive Vice President)

Danish National Biobank & Biomarkers
Congenital Disorders
Danish National Biobank
Prediagnostics & Service

Research - vaccines (Peter L. Andersen, Executive Vice President)

Infectious Disease Immunology
Vaccine Development

Research - epidemiology (Mads Melbye, President & CEO, Executive Vice President)

Epidemiology research 
Bandim Health Project